Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marta Lualdi has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Modeling Strategies for Neurodegenerative Diseases: In Vitro, In Vivo and In Silico Frameworks

    by Francesca Martorella, Camilla Cigolini, Giorgia Pupo, Tiziana Alberio, Marta Lualdi

    Neurodegenerative diseases (NDs) comprise a heterogeneous group of disorders characterized by complex etiologies, multifactorial pathogenic mechanisms, and remarkable clinical and molecular variability. Their increasing prevalence poses an important challenge to healthcare systems, society and the global economy. Despite decades of research, effective disease-modifying therapies remain elusive, highlighting the urgent need for reliable disease models capable of unraveling pathogenic mechanisms and supporting the development of personalized therapeutic strategies. Modeling NDs remains inherently challenging, since disease onset and progression arise from the interplay among genetic factors, environmental exposures, aging, and individual pathological conditions. Consequently, similar insults may lead to distinct molecular trajectories and clinical outcomes in different subjects. Reproducing this heterogeneity, together with the prolonged temporal evolution that characterizes NDs over decades in humans, represents a major limitation of current experimental models. Here, we provide a comprehensive overview of the modeling strategies currently available for the study of NDs, spanning conventional two-dimensional cellular systems, advanced patient-derived three-dimensional organoids, complementary in vivo animal models, and rapidly evolving in silico approaches. For each model category, we discuss its historical development, current applications, future perspectives, and, critically, principal strengths and limitations in reproducing disease biology and supporting translational research. We emphasize that the growing synergy between in vitro, in vivo, and in silico methodologies, empowered by multimodal data integration and artificial intelligence, is expected to accelerate biomarker discovery, improve disease modeling, reduce experimental burden, and ultimately foster the development of personalized disease-modifying therapies for NDs.

  • Open Access

    Modeling Strategies for Neurodegenerative Diseases: Current Advances and Future Directions

    by Francesca Martorella, Camilla Cigolini, Giorgia Pupo, Tiziana Alberio, Marta Lualdi

    Neurodegenerative diseases (NDs) comprise a heterogeneous group of disorders characterized by complex etiologies, multifactorial pathogenic mechanisms, and remarkable clinical and molecular variability. Their increasing prevalence poses an important challenge to healthcare systems, society and global economy. Despite decades of research, effective disease-modifying therapies remain elusive, highlighting the urgent need for reliable disease models capable of unraveling pathogenic mechanisms and supporting the development of personalized therapeutic strategies. Modeling NDs remains inherently challenging, since disease onset and progression arise from the interplay among genetic factors, environmental exposures, aging, and individual pathological conditions. Consequently, similar insults may lead to distinct molecular trajectories and clinical outcomes in different subjects. Reproducing this heterogeneity, together with the prolonged temporal evolution that characterizes NDs over decades in humans, represents a major limitation of current experimental models. Here we provide a comprehensive overview of the modeling strategies currently available for the study of NDs, spanning conventional two-dimensional cellular systems, advanced patient-derived three-dimensional organoids, complementary in vivo animal models, and rapidly evolving in silico approaches. For each model category, we discuss its historical development, current applications, future perspectives, and, critically, principal strengths and limitations in reproducing disease biology and supporting translational research. We emphasize that the growing synergy between in vitro, in vivo, and in silico methodologies, empowered by multimodal data integration and artificial intelligence, is expected to accelerate biomarker discovery, improve disease modeling, reduce experimental burden, and ultimately foster the development of personalized disease-modifying therapies for NDs.

  • Open Access

    Neurodegeneration Beyond Neurons: Emerging Insights from Molecular and Multi-Omics Approaches

    by Marta Lualdi

    Biological systems are inherently complex, with multiple components that interact with each other


  • Open Access

    Ligand-Based Regulation of Dynamics and Reactivity of Hemoproteins

    by Emily Samuela Turilli-Ghisolfi, Marta Lualdi, Mauro Fasano

    Hemoproteins include several heme-binding proteins with distinct structure and function. The presence of the heme group confers specific reactivity and spectroscopic properties to hemoproteins. In this review, we provide an overview of five families of hemoproteins in terms of dynamics and reactivity. First, we describe how ligands modulate cooperativity and reactivity in globins, such as myoglobin and hemoglobin. Second, we move on to another family of hemoproteins devoted to electron transport, such as cytochromes. Later, we consider heme-based reactivity in hemopexin, the main heme-scavenging protein. Then, we focus on heme–albumin, a chronosteric hemoprotein with peculiar spectroscopic and enzymatic properties. Eventually, we analyze the reactivity and dynamics of the most recently discovered family of hemoproteins, i.e., nitrobindins.


  • Open Access

    The Role of Rab Proteins in Mitophagy: Insights into Neurodegenerative Diseases

    by Adeena Shafique, Martina Brughera, Marta Lualdi, Tiziana Alberio

    Mitochondrial dysfunction and vesicular trafficking alterations have been implicated in the pathogenesis of several neurodegenerative diseases. It has become clear that pathogenetic pathways leading to neurodegeneration are often interconnected. Indeed, growing evidence suggests a concerted contribution of impaired mitophagy and vesicles formation in the dysregulation of neuronal homeostasis, contributing to neuronal cell death. Among the molecular factors involved in the trafficking of vesicles, Ras analog in brain (Rab) proteins seem to play a central role in mitochondrial quality checking and disposal through both canonical PINK1/Parkin-mediated mitophagy and novel alternative pathways. In turn, the lack of proper elimination of dysfunctional mitochondria has emerged as a possible causative/early event in some neurodegenerative diseases. Here, we provide an overview of major findings in recent years highlighting the role of Rab proteins in dysfunctional mitochondrial dynamics and mitophagy, which are characteristic of neurodegenerative diseases. A further effort should be made in the coming years to clarify the sequential order of events and the molecular factors involved in the different processes. A clear cause–effect view of the pathogenetic pathways may help in understanding the molecular basis of neurodegeneration.


  • Open Access

    Current Insights on Neurodegeneration by the Italian Proteomics Community

    by Tiziana Alberio, Martina Brughera, Marta Lualdi

    The growing number of patients affected by neurodegenerative disorders represents a huge problem for healthcare systems, human society, and economics. In this context, omics strategies are crucial for the identification of molecular factors involved in disease pathobiology, and for the discovery of biomarkers that allow early diagnosis, patients’ stratification, and treatment response prediction. The integration of different omics data is a required step towards the goal of personalized medicine. The Italian proteomics community is actively developing and applying proteomics approaches to the study of neurodegenerative disorders; moreover, it is leading the mitochondria-focused initiative of the Human Proteome Project, which is particularly important given the central role of mitochondrial impairment in neurodegeneration. Here, we describe how Italian research groups in proteomics have contributed to the knowledge of many neurodegenerative diseases, through the elucidation of the pathobiology of these disorders, and through the discovery of disease biomarkers. In particular, we focus on the central role of post-translational modifications analysis, the implementation of network-based approaches in functional proteomics, the integration of different omics in a systems biology view, and the development of novel platforms for biomarker discovery for the high-throughput quantification of thousands of proteins at a time.


  • Open Access

    Looking at COVID-19 from a Systems Biology Perspective

    by Emily Samuela Turilli, Marta Lualdi, Mauro Fasano

    The sudden outbreak and worldwide spread of the SARS-CoV-2 pandemic pushed the scientific community to find fast solutions to cope with the health emergency. COVID-19 complexity, in terms of clinical outcomes, severity, and response to therapy suggested the use of multifactorial strategies, characteristic of the network medicine, to approach the study of the pathobiology. Proteomics and interactomics especially allow to generate datasets that, reduced and represented in the forms of networks, can be analyzed with the tools of systems biology to unveil specific pathways central to virus–human host interaction. Moreover, artificial intelligence tools can be implemented for the identification of druggable targets and drug repurposing. In this review article, we provide an overview of the results obtained so far, from a systems biology perspective, in the understanding of COVID-19 pathobiology and virus–host interactions, and in the development of disease classifiers and tools for drug repurposing.


  • Open Access

    C9ORF72 Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALS

    by Marta Lualdi, Adeena Shafique, Edoardo Pedrini, Luisa Pieroni, Viviana Greco, Massimo Castagnola, Giorgia Cucina, Lucia Corrado, Alice Di Pierro, Fabiola De Marchi, et al.

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive degeneration of the corticospinal motor neurons, which ultimately leads to death. The repeat expansion in chromosome 9 open reading frame 72 (C9ORF72) represents the most common genetic cause of ALS and it is also involved in the pathogenesis of other neurodegenerative disorders. To offer insights into C9ORF72-mediated pathogenesis, we quantitatively analyzed the proteome of patient-derived primary skin fibroblasts from ALS patients carrying the C9ORF72 mutation compared with ALS patients who tested negative for it. Differentially expressed proteins were identified, used to generate a protein-protein interaction network and subjected to a functional enrichment analysis to unveil altered molecular pathways. ALS patients were also compared with patients affected by frontotemporal dementia carrying the C9ORF72 repeat expansion. As a result, we demonstrated that the molecular pathways mainly altered in fibroblasts (e.g., protein homeostasis) mirror the alterations observed in C9ORF72-mutated neurons. Moreover, we highlighted novel molecular pathways (nuclear and mitochondrial transports, vesicle trafficking, mitochondrial bioenergetics, glucose metabolism, ER-phagosome crosstalk and Slit/Robo signaling pathway) which might be further investigated as C9ORF72-specific pathogenetic mechanisms. Data are available via ProteomeXchange with the identifier PXD023866.


  • Low noncarbonic buffer power amplifies acute respiratory acid-base disorders in patients with sepsis: an in vitro study

    by Thomas Langer, Serena Brusatori, Eleonora Carlesso, Francesco Zadek, Paolo Brambilla, Chiara Ferraris Fusarini, Frantisek Duska, Pietro Caironi, Luciano Gattinoni, Mauro Fasano, et al.

    Patients with sepsis have typically reduced concentrations of hemoglobin and albumin, the major components of noncarbonic buffer power (β). This could expose patients to high pH variations during acid-base disorders. The objective of this study is to compare, in vitro, noncarbonic β of patients with sepsis with that of healthy volunteers, and evaluate its distinct components. Whole blood and isolated plasma of 18 patients with sepsis and 18 controls were equilibrated with different CO2 mixtures. Blood gases, pH, and electrolytes were measured. Noncarbonic β and noncarbonic β due to variations in strong ion difference (βSID) were calculated for whole blood. Noncarbonic β and noncarbonic β normalized for albumin concentrations (βNORM) were calculated for isolated plasma. Representative values at pH = 7.40 were compared. Albumin proteoforms were evaluated via two-dimensional electrophoresis. Hemoglobin and albumin concentrations were significantly lower in patients with sepsis. Patients with sepsis had lower noncarbonic β both of whole blood (22.0 ± 1.9 vs. 31.6 ± 2.1 mmol/L, P < 0.01) and plasma (0.5 ± 1.0 vs. 3.7 ± 0.8 mmol/L, P < 0.01). Noncarbonic βSID was lower in patients (16.8 ± 1.9 vs. 24.4 ± 1.9 mmol/L, P < 0.01) and strongly correlated with hemoglobin concentration (r = 0.94, P < 0.01). Noncarbonic βNORM was lower in patients [0.01 (−0.01 to 0.04) vs. 0.08 (0.06–0.09) mmol/g, P < 0.01]. Patients with sepsis and controls showed different amounts of albumin proteoforms. Patients with sepsis are exposed to higher pH variations for any given change in CO2 due to lower concentrations of noncarbonic buffers and, possibly, an altered buffering function of albumin. In both patients with sepsis and healthy controls, electrolyte shifts are the major buffering mechanism during respiratory acid-base disorders. NEW & NOTEWORTHY Patients with sepsis are poorly protected against acute respiratory acid-base derangements due to a lower noncarbonic buffer power, which is caused both by a reduction in the major noncarbonic buffers, i.e. hemoglobin and albumin, and by a reduced buffering capacity of albumin. Electrolyte shifts from and to the red blood cells determining acute variations in strong ion difference are the major buffering mechanism during acute respiratory acid-base disorders.


  • Features Selection and Extraction in Statistical Analysis of Proteomics Datasets

    by Marta Lualdi, Mauro Fasano

    “Omics” techniques (e.g., proteomics, genomics, metabolomics), from which huge datasets can nowadays be obtained, require a different way of thinking about data analysis that can be summarized with the idea that, when data are enough, they can speak for themselves. Indeed, managing huge amounts of data imposes the replacement of the classical deductive approach (hypothesis-driven) with a data-driven hypothesis-generating inductive approach, so to generate mechanistical hypotheses from data. Data reduction is a crucial step in proteomics data analysis, because of the sparsity of significant features in big datasets. Thus, feature selection/extraction methods are applied to obtain a set of features based on which a proteomics signature can be drawn, with a functional significance (e.g., classification, diagnosis, prognosis). Despite big data generated almost daily by proteomics studies, a well-established statistical workflow for data analysis in proteomics is still lacking, opening up to misleading and incorrect data analysis and interpretation. This chapter will give an overview of the methods available for feature selection/extraction in proteomics datasets and how to choose the most appropriate one based on the type of dataset.